Armata Pharmaceuticals In...

AMEX: ARMP · Real-Time Price · USD
2.55
0.02 (0.79%)
At close: Aug 15, 2025, 2:25 PM

Armata Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
5.17M 4.53M 5.51M 4.47M
Cost of Revenue
1.32M 33.77M 892K 20.02M
Gross Profit
3.85M -29.24M 4.62M -15.54M
Operating Income
-42.44M -40.89M -36.95M -23.82M
Interest Income
697K 179K 29K 5K
Pretax Income
-18.92M -69.05M -36.92M -23.16M
Net Income
-18.92M -69.05M -36.92M -23.16M
Selling & General & Admin
13.18M 11.65M 7.44M 8.28M
Research & Development
34.43M 33.77M 35.02M 20.02M
Other Expenses
n/a -33.77M -892K -20.02M
Operating Expenses
47.61M 11.65M 41.56M 8.28M
Interest Expense
10.74M 2.63M 29K 64K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
47.61M 45.42M 42.45M 28.3M
Income Tax Expense
n/a n/a -29K n/a
Shares Outstanding (Basic)
36.16M 36.08M 34.29M 24.1M
Shares Outstanding (Diluted)
59.06M 36.08M 34.29M 24.1M
EPS (Basic)
-0.52 -1.91 -1.08 -0.96
EPS (Diluted)
-0.32 -1.91 -1.08 -0.96
EBITDA
-6.85M -39.92M -36.05M -22.65M
EBIT
-8.17M -40.89M -36.92M -23.09M
Depreciation & Amortization
1.32M 972K 892K 1.17M